Literature DB >> 21160975

Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.

Michael C Kew1.   

Abstract

Occult hepatitis B virus (HBV) infection was shown to be present in 75% of Black Africans with hepatocellular carcinoma (HCC) in whom the tumor was hitherto not thought to be caused by chronic HBV infection. The association between chronic HBV infection and the development of the tumor is thus even closer than was originally thought. HBV viral load was found to be significantly higher in patients with HCC than in Black African controls. As in other populations, HBV e antigen-positive patients with hepatocellular carcinoma had significantly higher viral loads than patients negative for this antigen. The significance of this finding is discussed. The risk for HCC development with genotype A of HBV, the predominant genotype in African isolates, has not been investigated. Genotype A was shown to be 4.5 times more likely than other genotypes to cause HCC in Black Africans, and tumours occurred at a significantly younger age. Increasing numbers of patients with human immunodeficiency virus (HIV) and HBV co-infection are being reported to develop HCC. A preliminary case/control comparison supports the belief that HIV co-infection enhances the hepatocarcinogenic potential of HBV. A study from The Gambia provides the first evidence that dietary exposure to aflatoxin B(1) may cause cirrhosis and that this may play a contributory role in the pathogenesis of aflatoxin-induced HCC. An animal model has provided experimental support for the clinical evidence that dietary iron overload in the African is directly hepatocarcinogenic, in addition to causing the tumor indirectly through the development of cirrhosis.

Entities:  

Keywords:  Aflatoxin; Black Africans; Dietary iron overload; Hepatitis B viral loads; Hepatitis B virus genotype A; Hepatocellular carcinoma; Occult hepatitis B; Virus infection

Year:  2010        PMID: 21160975      PMCID: PMC2999270          DOI: 10.4254/wjh.v2.i2.65

Source DB:  PubMed          Journal:  World J Hepatol


  80 in total

1.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

2.  Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study.

Authors:  D Y Lin; I S Sheen; C T Chiu; S M Lin; Y C Kuo; Y F Liaw
Journal:  J Clin Ultrasound       Date:  1993-06       Impact factor: 0.910

3.  Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study.

Authors:  P C Turner; A Sylla; Y Y Gong; M S Diallo; A E Sutcliffe; A J Hall; C P Wild
Journal:  Lancet       Date:  2005 Jun 4-10       Impact factor: 79.321

4.  The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

Authors:  M Gómez-Gonzalo; M Carretero; J Rullas; E Lara-Pezzi; J Aramburu; B Berkhout; J Alcamí; M López-Cabrera
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

5.  Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis.

Authors:  Chao-Hung Hung; Sheng-Nan Lu; Jing-Houng Wang; Chuan-Mo Lee; Tsung-Ming Chen; Hung-Da Tung; Chien-Hung Chen; Wu-Shiung Huang; Chi-Sin Changchien
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

6.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Authors:  Patricia Arauz-Ruiz; Helene Norder; Betty H Robertson; Lars O Magnius
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

Review 7.  Hepatitis B virus genotypes.

Authors:  Anna Kramvis; Michael Kew; Guido François
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

8.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

9.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

10.  Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study.

Authors:  J Fung; M-F Yuen; J C-H Yuen; D K-H Wong; C-L Lai
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

View more
  22 in total

Review 1.  Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.

Authors:  Catherine Mn Croagh; Paul V Desmond; Sally J Bell
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Risk factors for hepatocellular carcinoma.

Authors:  D Alan Herbst; K Rajender Reddy
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

Review 3.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  Is there any value to hepatitis B virus genotype analysis?

Authors:  Sudeep Tanwar; Geoffrey Dusheiko
Journal:  Curr Gastroenterol Rep       Date:  2012-02

5.  Hepatitis B virus genotyping: is the time ripe for routine clinical use?

Authors:  Kaushal Madan; Pankaj Tyagi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 6.  Hepatitis B and C in African Americans: current status and continued challenges.

Authors:  Kimberly A Forde; Orapin Tanapanpanit; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

7.  Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.

Authors:  Julio A Gutierrez; Robert G Gish
Journal:  Transl Cancer Res       Date:  2013-12       Impact factor: 1.241

8.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

Review 9.  HBV induced HCC: major risk factors from genetic to molecular level.

Authors:  Ambreen Ayub; Usman Ali Ashfaq; Asma Haque
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

10.  Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).

Authors:  Chaohui Zuo; Man Xia; Qunfeng Wu; Haizhen Zhu; Jingshi Liu; Chen Liu
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.